Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis
Ascendant Diagnostics is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.
We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.
- Life Sciences
- 535 W. Research Center Blvd.
- Fayetteville, AR 72701
- Omid Moghadam,
- Chief Executive Officer
- Anna Daily, PhD,
- Senior Scientist
- Kimberley Fuller,
- Director of Market Research
- and Business Development
The awards honor Arkansas businesses that excel in the international marketplace, and will be presented at a Governor's Mansion luncheon on May 22. All Arkansas companies that sell in international markets are eligible to be nominated.
In late December when bloggers and TV show hosts recount the buzz words of 2014, no doubt "heartbleed" will occupy a place on each list.
Teams from the University of Arkansas won eight of the 10 awards presented Wednesday at the 2014 Donald W. Reynolds Governor's Cup collegiate business plan competition.
More than 80 students in grades 9-12 spent the weekend in Little Rock coming up with potential tech-based startup ventures as part of the first-ever High School Startup Weekend.